$15.73
2.67%
Downside
Day's Volatility :4.62%
Upside
2.0%
91.29%
Downside
52 Weeks Volatility :96.44%
Upside
59.14%
Period | Monopar Therapeutics Inc | Index (Russel 2000) |
---|---|---|
3 Months | 443.95% | 0.0% |
6 Months | 314.17% | 0.0% |
1 Year | 709.23% | 0.0% |
3 Years | -37.63% | -27.4% |
Market Capitalization | 68.2M |
Book Value | $1.73 |
Earnings Per Share (EPS) | -2.1 |
Wall Street Target Price | 18.0 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -53.45% |
Return On Equity TTM | -102.31% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
Diluted Eps TTM | -2.1 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -1.95 |
EPS Estimate Next Year | -2.48 |
EPS Estimate Current Quarter | -0.09 |
EPS Estimate Next Quarter | -0.1 |
What analysts predicted
Upside of 14.43%
Sell
Neutral
Buy
Monopar Therapeutics Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Monopar Therapeutics Inc | 210.63% | 314.17% | 709.23% | -37.63% | -88.09% |
Regeneron Pharmaceuticals, Inc. | -18.01% | -15.81% | -1.7% | 31.13% | 150.21% |
Biontech Se | -12.27% | 17.34% | 4.17% | -56.04% | 478.94% |
Alnylam Pharmaceuticals, Inc. | 2.34% | 76.9% | 60.41% | 45.24% | 198.24% |
Vertex Pharmaceuticals Incorporated | 10.04% | 20.33% | 30.51% | 156.8% | 152.08% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Monopar Therapeutics Inc | NA | NA | NA | -1.95 | -1.02 | -0.53 | NA | 1.73 |
Regeneron Pharmaceuticals, Inc. | 20.49 | 20.54 | 1.22 | 44.74 | 0.17 | 0.07 | NA | 272.04 |
Biontech Se | 160.8 | NA | 0.04 | -2.99 | -0.03 | -0.02 | NA | 85.17 |
Alnylam Pharmaceuticals, Inc. | NA | NA | -0.49 | -1.87 | -15.01 | -0.03 | NA | 0.25 |
Vertex Pharmaceuticals Incorporated | 32.84 | NA | 1.27 | 0.19 | -0.03 | 0.12 | NA | 60.66 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Monopar Therapeutics Inc | Buy | $59.7M | -88.09% | NA | 0.0% |
Regeneron Pharmaceuticals, Inc. | Buy | $91.1B | 150.21% | 20.49 | 33.61% |
Biontech Se | Buy | $26.5B | 478.94% | 160.8 | -18.75% |
Alnylam Pharmaceuticals, Inc. | Buy | $34.8B | 198.24% | NA | -15.86% |
Vertex Pharmaceuticals Incorporated | Buy | $121.6B | 152.08% | 32.84 | -4.51% |
Insights on Monopar Therapeutics Inc
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 45.8% return, outperforming this stock by 83.6%
monopar therapeutics inc., a biopharmaceutical company, engages in developing proprietary therapeutics to enhance clinical outcomes for cancer patients in the united states. it is involved in developing validive, a clonidine mucobuccal tablet that is in phase iii for the treatment of radiation induced severe oral mucositis in oropharyngeal cancer patients; camsirubicin, a topoisomerase ii-alpha targeted analog of doxorubicin engineered to retain anticancer activity and for minimizing toxic effects on the heart; and mnpr-101, a humanized monoclonal antibody for treating advanced solid cancers. the company has a collaboration grupo espaã±ol de investigaciã³n en sarcomas for the development of camsirubicin in patients with advanced soft tissue sarcoma; and northstar medical radioisotopes, llc to develop radio-immuno-therapeutics targeting severe covid-19. monopar therapeutics inc. was founded in 2014 and is headquartered in wilmette, illinois.
Organization | Monopar Therapeutics Inc |
Employees | 9 |
CEO | Dr. Christopher M. Starr Ph.D. |
Industry | Health Technology |
Cactus Acquisition Corp 1 Ltd
$15.73
-0.32%
Rigel Resource Acquisition Corp
$15.73
-0.32%
Everi Holdings Inc
$15.73
-0.32%
Anfield Us Equity Sector Rotation Etf
$15.73
-0.32%
Nordic American Tankers Limited
$15.73
-0.32%
3edge Dynamic Fixed Income Etf
$15.73
-0.32%
Direxion Daily Csi 300 China A Share 2x Shares Etf
$15.73
-0.32%
Dfa Dimensional Us Real Estate Etf
$15.73
-0.32%
Sow Good Inc
$15.73
-0.32%